Mueller T, Patel M V, Stevens L M. "Method for the Synthesis of 6-Methyl-2-(pyrazin-2-yl)-1,3,6,2-dioxazaborocane-4,8-dione" [P]. US Patent, US 10028891 B2, 2019-08-06.
参考文献 Literature
Yamamoto K, Tanaka H, Suzuki T. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Sep. Sci., 2019, 138, (6), 3138-3150.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Phytochemistry, 2015, 1470, 3579-3584.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 6-Methyl-2-(pyrazin-2-yl)-1,3,6,2-dioxazaborocane-4,8-dione Using HRMS and NMR". Environ. Sci. Technol., 2018, 1336, (1), 6967-6991.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2017, 312, (4), 3518-3547.